Most research reveals 30 to 40 percent of women in the United States say they have sexual issues. A recent study examined how many women consider their sex issues to be a problem. With host Dr. Lauren Streicher, Dr. Jan Shifren, an associate professor of obstetrics, gynecology and reproductive biology at Harvard Medical School, looks at the findings of her research. The two review the impetus for the study, questions that were asked from 30,000 participants, and what has been gleaned from the results. The two also touch on whether testosterone and Viagra should be prescribed to help women who are distressed by their sexual issues.
How to Help Women with Sexual Issues
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Most research reveals 30 to 40 percent of women in the United States say they have sexual issues. A recent study examined how many women consider their sex issues to be a problem. With host Dr. Lauren Streicher, Dr. Jan Shifren, an associate professor of obstetrics, gynecology and reproductive biology at Harvard Medical School, looks at the findings of her research. The two review the impetus for the study, questions that were asked from 30,000 participants, and what has been gleaned from the results. The two also touch on whether testosterone and Viagra should be prescribed to help women who are distressed by their sexual issues.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Level Up Your Skills: Tailoring Management of HF
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?